[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO844895L - Fremgangsmaate ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat - Google Patents

Fremgangsmaate ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat

Info

Publication number
NO844895L
NO844895L NO844895A NO844895A NO844895L NO 844895 L NO844895 L NO 844895L NO 844895 A NO844895 A NO 844895A NO 844895 A NO844895 A NO 844895A NO 844895 L NO844895 L NO 844895L
Authority
NO
Norway
Prior art keywords
procedure
preparation
new therapeutic
therapeutic active
sulphonamide derivative
Prior art date
Application number
NO844895A
Other languages
English (en)
Other versions
NO159998B (no
NO159998C (no
Inventor
Robert Michael Demarinis
Jacob Paul Hieble
Carl Kaiser
James William Wilson
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NO844895L publication Critical patent/NO844895L/no
Publication of NO159998B publication Critical patent/NO159998B/no
Publication of NO159998C publication Critical patent/NO159998C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02—Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO844895A 1983-12-07 1984-12-06 Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat. NO159998C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/559,151 US4507320A (en) 1983-12-07 1983-12-07 Dopaminergic agonist N,N-di-n-propyl-4-hydroxy-3-methanesulfonamidophenethylamine

Publications (3)

Publication Number Publication Date
NO844895L true NO844895L (no) 1985-06-10
NO159998B NO159998B (no) 1988-11-21
NO159998C NO159998C (no) 1989-03-01

Family

ID=24232466

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844895A NO159998C (no) 1983-12-07 1984-12-06 Analogifremgangsm te ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat.

Country Status (22)

Country Link
US (1) US4507320A (no)
EP (1) EP0147114B1 (no)
JP (1) JPS60139664A (no)
KR (1) KR850004586A (no)
AR (1) AR240555A1 (no)
AT (1) ATE26702T1 (no)
AU (1) AU565667B2 (no)
CA (1) CA1212959A (no)
DE (1) DE3463265D1 (no)
DK (1) DK550384A (no)
EG (1) EG16694A (no)
ES (2) ES8604497A1 (no)
FI (1) FI79836C (no)
GR (1) GR81145B (no)
HU (1) HU193722B (no)
IL (1) IL73471A (no)
NO (1) NO159998C (no)
NZ (1) NZ210053A (no)
PH (1) PH21807A (no)
PT (1) PT79618B (no)
ZA (1) ZA849459B (no)
ZW (1) ZW18784A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155268A (en) * 1984-05-04 1992-10-13 The Upjohn Company Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides
AU4945185A (en) * 1984-11-08 1986-05-15 Syntex (U.S.A.) Inc. Dialkyl aminoethylaniline derivatives
US4629730A (en) * 1985-04-11 1986-12-16 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4847269A (en) * 1985-04-11 1989-07-11 Syntex (U.S.A.) Inc. Method for treating intraocular hypertension
US4752621A (en) * 1985-04-11 1988-06-21 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US4642378A (en) * 1985-04-11 1987-02-10 Syntex (U.S.A.) Inc. Arylalkyl amines useful for lowering intraocular pressure
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
JP3312629B2 (ja) * 1991-01-23 2002-08-12 日産化学工業株式会社 アニリン誘導体及び製法
FR2724654B1 (fr) * 1994-09-16 1997-12-12 Roussel Uclaf Nouveaux derives de l'acide gallique, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
DE19842796A1 (de) * 1998-09-18 2000-03-30 Atochem Elf Deutschland Radikalbildner und Phlegmatisierungsmittel enthaltende Zusammensetzungen, Verwendungen und Verfahren zur Herstellung solcher Zusammensetzungen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (no) * 1962-01-24
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US3758692A (en) * 1969-04-14 1973-09-11 Mead Johnson & Co Ylamines sympathomimetic process and compositions employing sulfonamidophenalk
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts
US4219568A (en) * 1978-03-01 1980-08-26 University Patents, Inc. Method of increasing renal blood flow with dopamine derivatives
US4404224A (en) * 1981-12-02 1983-09-13 American Cyanamid Company Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof for increasing the growth rate and/or improving the lean meat to fat ratio of warm blooded animals

Also Published As

Publication number Publication date
IL73471A (en) 1987-12-20
ES548109A0 (es) 1986-05-01
HU193722B (en) 1987-11-30
JPS60139664A (ja) 1985-07-24
AU3532484A (en) 1985-06-13
ZA849459B (en) 1986-04-30
DK550384A (da) 1985-06-08
PH21807A (en) 1988-02-29
HUT37744A (en) 1986-02-28
EP0147114A1 (en) 1985-07-03
DE3463265D1 (de) 1987-05-27
PT79618A (en) 1985-01-01
FI844818L (fi) 1985-06-08
EP0147114B1 (en) 1987-04-22
IL73471A0 (en) 1985-02-28
CA1212959A (en) 1986-10-21
NO159998B (no) 1988-11-21
NZ210053A (en) 1987-06-30
AU565667B2 (en) 1987-09-24
ES538319A0 (es) 1986-02-01
DK550384D0 (da) 1984-11-20
ES8604497A1 (es) 1986-02-01
ES8606853A1 (es) 1986-05-01
KR850004586A (ko) 1985-07-25
EG16694A (en) 1988-09-30
PT79618B (en) 1986-11-18
ZW18784A1 (en) 1985-02-20
AR240555A1 (es) 1990-05-31
ATE26702T1 (de) 1987-05-15
NO159998C (no) 1989-03-01
FI844818A0 (fi) 1984-12-05
US4507320A (en) 1985-03-26
GR81145B (en) 1985-04-04
FI79836C (fi) 1990-03-12
FI79836B (fi) 1989-11-30

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO172181C (no) Fremgangsmaate ved fremstilling av et terapeutisk aktivt benzensulfonatsalt av amlodipin
NO167572C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat.
NO164653C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt indol-derivat.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO844879L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO851695L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-heteroaryl-tiazol-derivater
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO814055L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive thienopyridinonderivater
NO844895L (no) Fremgangsmaate ved fremstilling av et nytt terapeutisk aktivt sulfonamidderivat
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO170021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater
NO150916C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt fenoksypropanolaminderivat
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO168100C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt fenolderivat
NO843377L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater